Literature DB >> 7534339

The dopamine transporter: immunochemical characterization and localization in brain.

B J Ciliax1, C Heilman, L L Demchyshyn, Z B Pristupa, E Ince, S M Hersch, H B Niznik, A I Levey.   

Abstract

Antibodies specific for the dopamine transporter (DAT) was developed and characterized by immunoblot analysis, immunoprecipitation, and immunocytochemistry, and used for immunolocalization of transporter protein in rat brain at the light microscopic level. Antibodies targeting the N-terminus, the second extracellular loop, and the C-terminus were generated from fusion proteins containing amino acid sequences from these respective regions. Immunoblot analysis demonstrated that N-terminus and loop antibodies were specific for expressed cloned DAT, recognized transporter protein in rat and human striatal membranes, and were sensitive to preabsorption with excess homologous fusion protein. Immunoprecipitation studies demonstrated that anti-DAT antisera recognized solubilized, radiolabeled DAT protein in a concentration-dependent manner. DAT immunocytochemistry with these antibodies were also sensitive to preabsorption with fusion protein and to lesions of dopaminergic mesostriatal and mesocorticolimbic pathways. Regional distribution of DAT coincided with established dopaminergic innervation of several regions, including ventral mesencephalon, medial forebrain bundle, and dorsal and ventral striatum. However, certain mismatches between immunocytochemical distributions of DAT and tyrosine hydroxylase were apparent, indicating that dopaminergic systems are heterogeneous and may use independent mechanisms for the regulation of dopamine levels in brain. The generation of specific DAT antibodies will permit further characterization of the cellular and subcellular localization of DAT protein, and of dopaminergic circuits in neurological and psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534339      PMCID: PMC6578165     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  144 in total

1.  Electrophysiological and morphological evidence for a GABAergic nigrostriatal pathway.

Authors:  M Rodríguez; T González-Hernández
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

2.  Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.

Authors:  S J Cragg; S A Greenfield
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

3.  Sonic hedgehog promotes the survival of specific CNS neuron populations and protects these cells from toxic insult In vitro.

Authors:  N Miao; M Wang; J A Ott; J S D'Alessandro; T M Woolf; D A Bumcrot; N K Mahanthappa; K Pang
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

Review 4.  Neuroimaging in drug abuse.

Authors:  Kimberly P Lindsey; S John Gatley; Nora D Volkow
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

5.  Limited convergence of rhinal cortical and dopaminergic inputs in the rat basolateral amygdala: an ultrastructural analysis.

Authors:  Courtney R Pinard; Franco Mascagni; Jay F Muller; Alexander J McDonald
Journal:  Brain Res       Date:  2010-03-24       Impact factor: 3.252

6.  Expression and distribution of dopamine transporter in cardiac tissues of the guinea pig.

Authors:  Alejandro Reynoso Palomar; Berenice Navarrete Larios; Victoria Chagoya De Sánchez; Lidia Martínez Pérez; Fidel De La Cruz López; Gonzalo Flores; Maria de Jesús Gómez-Villalobos
Journal:  Neurochem Res       Date:  2010-12-19       Impact factor: 3.996

7.  Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin.

Authors:  Ashley N Hutchinson; Jie V Deng; Dipendra K Aryal; William C Wetsel; Anne E West
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

8.  Dopamine transporter density of basal ganglia assessed with [123I]IPT SPET in obsessive-compulsive disorder.

Authors:  Chan-Hyung Kim; Min-Seong Koo; Keun-Ah Cheon; Young-Hoon Ryu; Jong-Doo Lee; Hong-Shick Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-25       Impact factor: 9.236

9.  Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs.

Authors:  O Cases; C Lebrand; B Giros; T Vitalis; E De Maeyer; M G Caron; D J Price; P Gaspar; I Seif
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

10.  Carriers of a common variant in the dopamine transporter gene have greater dementia risk, cognitive decline, and faster ventricular expansion.

Authors:  Florence F Roussotte; Boris A Gutman; Derrek P Hibar; Sarah K Madsen; Katherine L Narr; Paul M Thompson
Journal:  Alzheimers Dement       Date:  2014-12-10       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.